• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Curr.Med. Chem._Martínez, A._2015 - digital
Curr.Med. Chem._Martínez, A._2015 - digital

... to molecules where an AChE inhibitor is linked to other active compounds and finally to compounds able to interact simultaneously with two targets involved in AD. The importance of the multitarget strategy in complex diseases as neurodegenartive ones, especially Alzheimer disease, will be here descr ...
Newsletter What’s Inside
Newsletter What’s Inside

... stabilization within the host organism and introduce the infection effectively. I am impressed with the depth of nanoparticles in Mother Nature. From another viewpoint, that of clarifying the structure and function of nanoparticles in nature, significant progress has been made in the synthesis and f ...
Drugs of Abuse - Southwestern University
Drugs of Abuse - Southwestern University

... substance under medical supervision. »» Examples of Schedule I substances include heroin, gamma ...
Over-the-Counter Medications: A Success Story
Over-the-Counter Medications: A Success Story

... FDA asks if it should propose OTC marketing “in the absence of support from the drug sponsor” and, more generally, if FDA should be “more active in initiating switches.” Today, virtually every switch is accomplished through the new drug approval (NDA) process. This makes public health sense. The com ...
Search algorithms as a framework for the optimization of drug
Search algorithms as a framework for the optimization of drug

... screening of large libraries of compounds in multi-well plate formats, is now more and more available to the scientific community. It is useful to regard the information processing by our experimental systems as parallel biological computations, since the algorithms we are using are indeed derived f ...
NIZORAL 200 MG TABLETS
NIZORAL 200 MG TABLETS

... unless the benefits outweigh the potentially increased risks of side effects. If coadministration cannot be avoided, clinical monitoring for signs or symptoms of increased or prolonged effects or side effects of the interacting drug is recommended, and its dosage should be reduced or interrupted as ...
Animal Drug User Fee Programs Updated August 4, 2008 Sarah A. Lister
Animal Drug User Fee Programs Updated August 4, 2008 Sarah A. Lister

... The Animal Drug User Fee Act of 2003 (ADUFA I, P.L. 108-130) gave the Food and Drug Administration (FDA) initial authority to collect user fees from sponsors for the review of animal drug applications. ADUFA mirrors fee programs for human drugs and medical devices. Program authority sunsets October ...
FORMULATION AND EVALUATION OF THERMOSENSITIVE IN SITU GEL OF SALBUTAMOL
FORMULATION AND EVALUATION OF THERMOSENSITIVE IN SITU GEL OF SALBUTAMOL

... metabolized via liver in high degree and gives undesirably slow effects13. For this parenteral route is preferred but it is undesirable or impractical if drug is intended for the treatment of chronic disease, so alternative route is preferred; also transdermal route is used for drug delivery but its ...
Alzheimers consultee and commentator comments
Alzheimers consultee and commentator comments

... decision and the basis upon which it was made. Dementia is a devastating condition for the person developing the illness and for their families. It is a frightening disease and it can make people feel more afraid and worthless as symptoms progress. The current draft decision suggests that the experi ...
International Journal for Pharmaceutical Research Scholars (IJPRS)
International Journal for Pharmaceutical Research Scholars (IJPRS)

... Tablet is the most popular dosage forms existing today because of its convenience of selfadministration, compactness and easy manufacturing; however the problem of swallowing is common fact which leads to poor patient compliance. To overcome this drawback, fast dissolving tablets (FDT) has emerged a ...
Phencyclidine (PCP) - Center for Substance Abuse Research
Phencyclidine (PCP) - Center for Substance Abuse Research

... sold in vanilla extract bottles. PCP is also mixed with dyes to produce colored powder, tablets or capsules.1 It is currently a Schedule II controlled substance. History First synthesized in 1926, PCP was developed by Parke, Davis and Company under the trade name Sernyl for use as a general anesthet ...
The Usefulness of a Closed-system Device for the Mixing of
The Usefulness of a Closed-system Device for the Mixing of

... preparation processing of anti­ cancer drugs is 500 yen. Most of the cost of personal protection equipment and closed system devices for preventing exposure to anticancer drugs are currently paid for by the hospital. This economic issue causes difficulties in the discussion of measures to prevent ex ...
DEVELOPMENT AND CHARACTERIZATION OF CO-GROUND MIXTURES AND SOLID
DEVELOPMENT AND CHARACTERIZATION OF CO-GROUND MIXTURES AND SOLID

... for the production of micronized and stable drug particles. Many authors have reported on the use of this method for the enhancement of dissolution rates of various drugs. Examples include Aceclofenac and Neusilin [7] Indomethacin, Furosemide and Naproxen [8]. Amorphous solid dispersion solution exh ...
Introduction to Pharmacokinetics and Pharmacodynamics
Introduction to Pharmacokinetics and Pharmacodynamics

... For some drugs, the effectiveness can decrease with continued use. This is referred to as tolerance. Tolerance may be caused by pharmacokinetic factors, such as increased drug metabolism, that decrease the concentrations achieved with a given dose. There can also be pharmacodynamic tolerance, which ...
Coming Off Psychiatric Drugs
Coming Off Psychiatric Drugs

... diagnosis and medication. I learned that mistreatment like I went through is often business as usual in the mental health profession. I came across research ignored by the mainstream media, including studies by the UK charity MIND and the British Psychological Society, which confirmed my experience: ...
Attention Deficit Hyperactivity Disorder (ADHD) Evaluating Prescription Drugs Used to Treat:
Attention Deficit Hyperactivity Disorder (ADHD) Evaluating Prescription Drugs Used to Treat:

... These medicines don’t cure ADHD but they can keep symptoms, such as hyperactivity and impulsivity, under control, which may improve a person’s daily functioning. However, there is no good evidence showing that these benefits last for longer than two years, so you may want to periodically discuss wit ...
Fixed Dose Combinations & Rational Pharmacotherapeutics DR
Fixed Dose Combinations & Rational Pharmacotherapeutics DR

... • FDCs of Nimesulide + Paracetamol : Nimesulide alone is more antipyretic than paracetamol, more antiinflammatory than aspirin, and equivalent in analgesia to any of the NSAIDS alone. Efficacy gains unlikely with added Paracetamol and pts are subjected to increased hepatotoxic effects from the combo ...
Optimal Futures for Risk Evaluation and Mitigation Strategies (REMS)
Optimal Futures for Risk Evaluation and Mitigation Strategies (REMS)

... It is important to note that FDA policy on REMS thus far has been developed on a case-by-case basis between the agency and the sponsor. However, FDA has taken steps to engage various stakeholder groups, such as holding a meeting on May 4-5, 2009, with healthcare providers and representatives of the ...
rajiv gandhi university of health sciences
rajiv gandhi university of health sciences

... Amongst the various routes of drug delivery, the oral route is most preferred to the patient and the clinician alike. However, oral administration of drugs has disadvantages such as hepatic first pass metabolism and enzymatic degradation within the gastro intestinal (GIT), that prohibit oral adminis ...
Coming Off Psychiatric Drugs
Coming Off Psychiatric Drugs

... In a culture polarized between the pro-medication propaganda of pharmaceutical companies on the one hand, and the anti-medication agenda of some activists on the other, we offer a harm reduction approach to help people make their own decisions. We also present ideas and information for people who de ...
Pharma-Data 2012
Pharma-Data 2012

... The high investment level demonstrates that the pharmaceutical industry continued to focus on innovation despite the economic crisis. The chronological dynamic of this development is particularly interesting: while the overall internal R&D investment level of the German economy decreased by 1.7 % in ...
Paper in PDF - Open Science Online
Paper in PDF - Open Science Online

... normotensive people. Besides, a higher proportion of latanoprost-treated patients was found to maintain or increase their treatment effect over time than the timolol-treated patients.5,7 It has been proposed that the increase in latanoprost’s hypotensive effect occurring after weeks of treatment cou ...
The cardiotoxicity of macrolides: the role of interactions
The cardiotoxicity of macrolides: the role of interactions

... [32]. The clinical relevance of the consequential increased serum concentrations and/or elimination half-life of the substrate depends on the degree of accumulation, the therapeutic window of the substrate and the presence or absence of alternative pathways of elimination. Mechanism-based inhibition ...
Module 1. General Clinical Pharmacy.Clinical Pharmacy in
Module 1. General Clinical Pharmacy.Clinical Pharmacy in

... 33. What is the way of noradrenalin using? A. * Intravenous. B. Intramuscular. C. Per oral. D. Subcutaneous. E. Intracutaneous. 34. What is the effect of noradrenalin using? A. Vasodilating. B. * Vasoconstrictive. C. Bronchodilating. D. Bronchoconstrictive. E. Analeptic. 35. Angina pectoris is: A. * ...
METHODS OF STUDYING BIOAVAILABILITY AND BIOEQUIVALENCE  INTRODUCTION:
METHODS OF STUDYING BIOAVAILABILITY AND BIOEQUIVALENCE INTRODUCTION:

... – Direct and indirect methods may be used to assess drug bioavailability. – The in-vivo bioavailability of a drug product is demonstrated by the rate and extent of drug absorption, as determined by comparison of measured parameters, eg, concentration of the active drug ingredient in the blood, cumul ...
< 1 ... 13 14 15 16 17 18 19 20 21 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report